Senti Biosciences Holdings, Inc. Balance Sheet
SNTI|4 years of annual SEC 10-K data (FY2022-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 4 fiscal years. All figures from audited SEC 10-K filings.
Senti Biosciences Holdings, Inc. had $51M in total assets and $26M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash & Equivalents | $16.4M | $48.3M | $35.9M | $57.6M |
| Accounts Receivable | - | - | - | $626.0K |
| Current Assets | $23.3M | $59.0M | $71.2M | $102.6M |
| PP&E (Net) | $12.9M | $21.3M | $25.3M | $56.1M |
| Total Assets | $51.2M | $97.8M | $119.5M | $180.8M |
| Current Liabilities | $14.0M | $13.1M | $12.7M | $18.1M |
| Shareholders' Equity | $25.6M | $66.9M | $127.3M | -$111.5M |